美国否决一项关于维生素D的健康声称申请_外讯导读_食品资讯_食品伙伴罐�/title>

　　 食品伙伴网讯据美国食品药�?a href='//www.sqrdapp.com/news/tag_4604.html' class='zdbq' title='管理相关食品资讯' target='_blank'>管理局＇�a href='//www.sqrdapp.com/news/tag_12.html' class='zdbq' title='FDA相关食品资讯' target='_blank'>FDA）消息，近日，美国FDA发布通告，否决一项关亍�a href='//www.sqrdapp.com/news/tag_2506.html' class='zdbq' title='维生素D相关食品资讯' target='_blank'>维生素D皃�a href='//www.sqrdapp.com/news/tag_896.html' class='zdbq' title='健康声称相关食品资讯' target='_blank'>健康声称申请�

　　据了解，本次健康声称申请的内容为��摄取维生素D可减少多发性硬化症发生的风�?rdquo;，由Burdock Group代表拜耳公司提出。多发性硬化症是一种可损害人体中枢神经系统的慢性自身免疫性疾病、�/div>

　　美国FDA对申请材料进行评估认为，没有可靠的证据表明摄入维生素D会降低多发性硬化症的风险、�/div>

　　部分原文报道如下９�/div>

　　The U.S. Food and Drug Administration today denied a request for use of a qualified health claim that co nsumption of vitamin D may reduce the risk of developing multiple sclerosis （MS）， a chro nic autoimmune disorder that damages the body's central nervous system.

　　The FDA thoroughly reviewed the 85 publications submitted by the Burdock Group on behalf of Bayer, as well as all the publications cited in the petition's appendix. The agency also co nducted a vast independent literature review of hundreds of additio nal publications. Through this rigorous assessment, the FDA determined that scientific co nclusions could not be drawn a bout the relatio nship between vitamin D intake and MS risk. ba sed on the agency's review of the totality of publicly available scientific evidence, the FDA has co ncluded that there is no credible evidence of a relatio nship between intake of vitamin D and a reduced risk of MS.

本文由食品伙伴网食品资讯中心编辑，供网友参考，欢迎转载，转载请注明出处！有任何疑问，请联系news@www.sqrdapp.com、�/span>